Integrin alpha V beta 5 is one of five alpha V integrins and the only known beta 5 integrin (1‑3). The non‑covalent heterodimer of 170 kDa alpha V and 100‑110 kDa beta 5 integrin type I transmembrane glycoprotein subunits is expressed on a wide variety of cell types including keratinocytes, fibroblasts, adhesive monocytes, embryonic stem cells, and select endothelium and epithelium (4‑8). alpha V beta 5 binds ligands containing an RGD motif, notably vitronectin (1‑10). The 958 aa mouse alpha V extracellular domain (ECD) shares 92‑95% aa sequence identity with human and bovine alpha V, while the 696 aa mouse beta 5 ECD shares 97%, 91% and 91% aa sequence identity with rat, human and bovine beta 5, respectively. The alpha V ECD contains an N‑terminal beta ‑propeller structure, followed by domains termed thigh, calf‑1 and calf‑2 (1). The 799 aa beta 5 contains a vWFA domain within the ECD, which interacts with the alpha V beta ‑propeller to form a binding domain. Each subunit has a transmembrane sequence and a short cytoplasmic tail. Potential beta 5 isoforms include a 691 aa form with an alternate start site at aa 109, a 958 aa form with an alternate N‑terminus, and a 795 aa form with an alternate C‑terminus. Post‑translational modifications, such as proteolytic cleavage of the alpha V subunit or phosphorylation of the beta 5 cytoplasmic tail, can increase endocytic turnover of the alpha V beta 5 protein and/or promote cell migration (7‑10). Growth factors that increase PKC activity, such as VEGF or TGF‑ alpha, promote alpha V beta 5-mediated angiogenesis while alpha V beta 3, which may be expressed in the same cell, responds to FGF‑basic and TNF‑ alpha (11). An inhibitor of both down‑regulates tumor angiogenesis (12). During lung inflammation, up‑regulation of alpha V beta 5 on myofibroblasts or infiltrating lymphocytes may contribute to fibrosis by freeing TGF‑ beta from latency (13, 14). On retinal pigment epithelia, alpha V beta 5 is important for normal diurnal phagocytosis of outer rod segments, and contributes to adhesion of retinal cells (15).
Recombinant Mouse Integrin alpha V beta 5 Protein, CF
R&D Systems | Catalog # 7706-AV
Key Product Details
- R&D Systems CHO-derived Recombinant Mouse Integrin alpha V beta 5 Protein (7706-AV)
- Quality control testing to verify active proteins with lot specific assays by in-house scientists
- All R&D Systems proteins are covered with a 100% guarantee
Source
Accession Number
Structure / Form
Applications
Product Specifications
Source
| Mouse Integrin alpha V (Phe31-Val988) Accession # P43406 |
HP | GS Linker | Acidic Tail | HHHHHH | |
| Mouse Integrin beta 5 (Gly24-Asn719) Accession # NP_001139356 |
HP | GS Linker | Basic Tail | ||
| N-terminus | C-terminus | ||||
Purity
Endotoxin Level
N-terminal Sequence Analysis
Predicted Molecular Mass
SDS-PAGE
Activity
Measured by its binding ability in a functional ELISA.
When Recombinant Human Vitronectin (Catalog # 2308-VN) is coated at 1 μg/mL, Recombinant Mouse Integrin alpha V beta 5 binds with an apparent KD <0.5 nM.
Formulation, Preparation, and Storage
7706-AV
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
| Reconstitution | Reconstitute at 300 μg/mL in PBS.
Loading...
|
| Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Calculators
Background: Integrin alpha V beta 5
References
- Hynes, R.O. (2002) Cell 110:673.
- Suzuki, S. et al. (1987) J. Biol. Chem. 262:14080.
- Suzuki, S. et al. (1990) Proc. Natl. Acad. Sci. USA 87:5354.
- Smith, J.W. et al. (1990) J. Biol. Chem. 265:11008.
- Pasqualini, R. et al. (1993) J. Cell Sci. 105:101.
- Braam, S.R. et al. (2008) Stem Cells 26:2257.
- Memmo, L.M. and P. McKeown-Longo (1998) J. Cell Sci. 111:425.
- Kim, J.P. et al. (1994) J. Biol. Chem. 269:26926.
- Berthet, V. et al. (2004) FEBS Lett. 557:159.
- Li, Z. et al. (2010) Mol. Biol. Cell 21:3317.
- Friedlander, M. et al. (1995) Science 270:1500.
- Desgrosellier, J.S. and D.A. Cheresh (2010) Nat. Rev. Cancer 10:9.
- Wipff, P.J. et al. (2007) J. Cell Biol. 179:1311.
- Luzina, I.G. et al. (2009) Arthritis Rheum. 60:1530.
- Nandrot, E.F. et al. (2004) J. Exp. Med. 200:1539.
Alternate Names
Entrez Gene IDs
Gene Symbol
Additional Integrin alpha V beta 5 Products
Product Documents for Recombinant Mouse Integrin alpha V beta 5 Protein, CF
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Note: Certificate of Analysis not available for kit components.
Product Specific Notices for Recombinant Mouse Integrin alpha V beta 5 Protein, CF
For research use only
Related Research Areas
Citations for Recombinant Mouse Integrin alpha V beta 5 Protein, CF
Customer Reviews for Recombinant Mouse Integrin alpha V beta 5 Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Mouse Integrin alpha V beta 5 Protein, CF and earn rewards!
Have you used Recombinant Mouse Integrin alpha V beta 5 Protein, CF?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
FAQs for Recombinant Mouse Integrin alpha V beta 5 Protein, CF
-
Q: What is the amino acid sequence of the acidic and basic tails?
A: Acidic and basic tails are added to the protein to help facilitate optimal activity. While we generally include sequence information on the product datasheet, the sequences of these tails are considered confidential information.